Nordwand Advisors’s ProPhase Labs PRPH Stock Holding History

Nordwand Advisors’s Portfolio PRPH Stock Details PRPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,000	Closed	-$4.58K	–	156
2025 Q3	$4.58K	Buy	+1,000	New	+$3.87K	﹤0.01%	154
2025 Q2	–	Sell	-1,000	Closed	-$4.04K	–	204
2025 Q1	$4.04K	Buy	+1,000	New	+$4.59K	﹤0.01%	96

Other funds holding PRPH

Sykon Capital Harrison, New York $325M AUM 19.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $104B AUM 28.3% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Nordwand Advisors's PRPH Position: Q4 2025 in Review

Nordwand Advisors sold out of ProPhase Labs (PRPH) in Q4 2025, closing a stake of 1,000 shares — an estimated $4.58K sold.

Nordwand Advisors first reported a position in PRPH in Q1 2025 and held it in 2 quarters. The position peaked at $4.58K in Q3 2025. 17 funds tracked by Wall St. Rank hold PRPH as of Q4 2025.

Nordwand Advisors reported no remaining ProPhase Labs position as of Q4 2025 after selling out during the quarter.
Nordwand Advisors sold 1,000 ProPhase Labs shares in Q4 2025, an estimated $4.58K.
Nordwand Advisors first reported a position in ProPhase Labs in Q1 2025 and held it in 2 quarters.
Nordwand Advisors's ProPhase Labs position peaked at $4.58K in Q3 2025.
17 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2025.

Based on Nordwand Advisors's 13F filing for Q4 2025, filed 3 Feb 2026.